RARE icon

Ultragenyx Pharmaceutical
RARE

Overview Fund Activity

161 hedge funds and large institutions have $1.81B invested in Ultragenyx Pharmaceutical in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 60 increasing their positions, 59 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
161
Holders Change
–
Holders Change %
0%
% of All Funds
4.3%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
22
Increased
60
Reduced
59
Closed
21
Calls
$5.47M
Puts
$6.35M
Net Calls
-$876K
Net Calls Change
+$403K

Top Buyers

1
PAMU
Pictet Asset Management (UK)
United Kingdom
$14.2M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$77.9M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
$16.5M
4
Millennium Management
Millennium Management
New York
$22.6M
5
Goldman Sachs
Goldman Sachs
New York
$31.1M

Top Sellers

1
VAM
Visium Asset Management
New York
$0
2
Citadel Advisors
Citadel Advisors
Florida
$0
3
RIM
RS Investment Management
California
$978K
4
Wells Fargo
Wells Fargo
California
$65.9M
5
Allianz Asset Management
Allianz Asset Management
Germany
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$14.2M +$13.7M +186,927 +2,460%
JPMorgan Chase & Co
27
JPMorgan Chase & Co
New York
$12.9M +$284K +5,806 +2%
Geode Capital Management
28
Geode Capital Management
Massachusetts
$12.9M +$269K +5,508 +2%
Brown Advisory
29
Brown Advisory
Maryland
$12.8M +$3.01M +61,526 +31%
Axa
30
Axa
France
$11.1M -$968K -19,786 -8%
CCI
31
Columbus Circle Investors
$9.1M -$2.45M -50,180 -21%
TA
32
Teachers Advisors
New York
$8.45M +$406K +8,308 +5%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$8.39M -$261K -5,333 -3%
Charles Schwab
34
Charles Schwab
California
$8.36M +$101K +2,071 +1%
O
35
OrbiMed
New York
$8.28M +$2.01M +41,000 +32%
Deutsche Bank
36
Deutsche Bank
Germany
$7.75M -$2.83M -57,811 -27%
TCIM
37
TIAA CREF Investment Management
New York
$7.47M -$267K -5,468 -3%
BIM
38
BlackRock Investment Management
Delaware
$7.46M +$80.2K +1,640 +1%
VOYA Investment Management
39
VOYA Investment Management
Georgia
$7.24M +$502K +10,269 +7%
RSCM
40
Rock Springs Capital Management
Maryland
$6.92M +$1.12M +23,000 +19%
CS
41
Credit Suisse
Switzerland
$6.91M +$2.74M +56,038 +66%
IHM
42
Iguana Healthcare Management
New York
$6.85M +$978K +20,000 +17%
Royal Bank of Canada
43
Royal Bank of Canada
Ontario, Canada
$6.53M +$878K +17,941 +16%
BBA
44
Baker Bros. Advisors
New York
$5.42M -$636K -13,000 -10%
CAM
45
Cormorant Asset Management
Massachusetts
$5.42M +$65.6K +1,342 +1%
SFM
46
Sphera Funds Management
Israel
$5.14M +$5.14M +105,000 New
HCMT
47
Highland Capital Management (Texas)
Texas
$4.48M +$4.48M +91,500 New
TCM
48
Tekla Capital Management
Massachusetts
$4.32M – – –
EAM
49
Eventide Asset Management
Massachusetts
$4.28M – – –
PI
50
Putnam Investments
Massachusetts
$4.06M +$891K +18,209 +28%
1
2
3 4 5